| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 37,194,935 | 39,463,410 | 11,686,620 | | Cost of Revenue | 25,219,533 | 25,958,390 | 12,001,295 | | | Gross Profit | 11,975,402 | 13,505,020 | (314,675) | | | Operating Expenses | | Research Development | 2,286,533 | 2,399,354 |
-
| | Selling General and Administrative | 8,912,123 | 8,592,899 | 655,359 | | Non Recurring | 329,870 | (215,043) |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 446,875 | 2,727,811 | (970,034) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 29,604 | 4,259,627 | 128,222 | | Earnings Before Interest And Taxes | 476,479 | 6,987,438 | (841,812) | | Interest Expense | 346,786 | 410,939 | 186,558 | | Income Before Tax | 129,692 | 6,576,499 | (1,028,370) | | Income Tax Expense | 403,174 | 916,144 | (266,313) | | Minority Interest | (4,229) | (7,365) |
-
| | | | Net Income From Continuing Ops | (250,927) | 6,776,813 | (762,057) | | | Non-recurring Events | | Discontinued Operations | (11,278) | (637,766) |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (262,204) | 6,139,047 | (762,057) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($262,204) | $6,139,047 | ($762,057) |
|
1.23% Nasdaq 
Income Statement
